Search Results - Xiaocui Bu

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Response Gene to Complement 32 promotes cell proliferation and tamoxifen resistance in breast cancer via elevated FoxM1 expression.

    Response Gene to Complement 32 promotes cell proliferation and tamoxifen resistance in breast cancer via elevated FoxM1 expression. by Xinlei Li, Yan Liu, Zhiqian Wang, Xiaocui Bu, Yu Wang, Wei Zhang, Peng Zhao

    Published 2025-01-01

    Despite the high sensitivity of estrogen receptor positive (ER+) breast cancer to endocrine therapy, many patients have primary resistance or develop resistance to endocrine therapies. Acquired resistance to endocrine therapy is a great challenge in the treatment of ER+ breast cancer patient. Here w...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Response Gene to Complement 32 promotes cell proliferation and tamoxifen resistance in breast cancer via elevated FoxM1 expression

    Response Gene to Complement 32 promotes cell proliferation and tamoxifen resistance in breast cancer via elevated FoxM1 expression by Xinlei Li, Yan Liu, Zhiqian Wang, Xiaocui Bu, Yu Wang, Wei Zhang, Peng Zhao

    Published 2025-01-01 Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Efficient killing of radioresistant breast cancer cells by cytokine-induced killer cells

    Efficient killing of radioresistant breast cancer cells by cytokine-induced killer cells by Qingming Guo, Danni Zhu, Xiaocui Bu, Xiaofang Wei, Changyou Li, Daiqing Gao, Xiaoqiang Wei, Xuezhen Ma, Peng Zhao

    Published 2017-03-01

    Recurrence of breast cancer after radiotherapy may be partly explained by the presence of radioresistant cells. Thus, it would be desirable to develop an effective therapy against radioresistant cells. In this study, we demonstrated the intense antitumor activity of cytokine-induced killer cells aga...

    Full description

    Get full text
    Article

    Save to List
    Saved in:

Search Tools: